Stock Events

PTC Therapeutics (BH3.F) Q2 2024 Earnings

25AprConfirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-2.43
-1.66
-0.9
-0.13

Details

Expected EPS
-1.1903127105000002
Actual EPS
-1.120536
Surprise EPS
0.07
Surprise Percent
+5.86%

Description

PTC Therapeutics (BH3.F) has reported earnings of -1.120536 per share for Q2 2024.

0 Comments

Share your thoughts